Evidence map›Paper›PMID 28505090›Full record

ArticleToxins2017

Evaluation of Ochratoxin Recognition by Peptides Using Explicit Solvent Molecular Dynamics.

Aby A Thyparambil, Ingrid Bazin, Anthony Guiseppi-Elie

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Aby A ThyparambilCenter for Bioelectronics, Biosensors and Biochips (C3B), The College of Engineering, Texas A&M University, College Station, TX 77843, USA. athypar@tamu.edu.
Ingrid BazinEcole des mines d'Ales, institut Mines, Telecom, 6 avenue de Clavieres, Ales cedex30319, France. ingrid.bazin@mines-ales.fr.
Anthony Guiseppi-ElieCenter for Bioelectronics, Biosensors and Biochips (C3B), The College of Engineering, Texas A&M University, College Station, TX 77843, USA. guiseppi@tamu.edu.
BioElectronics (United States) · USVirginia BioTechnology Research Park · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biosensing platforms based on peptide recognition provide a cost-effective and stable alternative to antibody-based capture and discrimination of ochratoxin-A (OTA) vs. ochratoxin-B (OTB) in monitoring bioassays. Attempts to engineer peptides with improved recognition efficacy require thorough structural and thermodynamic characterization of the binding-competent conformations. Classical molecular dynamics (MD) approaches alone do not provide a thorough assessment of a peptide's recognition efficacy. In this study, in-solution binding properties of four different peptides, a hexamer (SNLHPK), an octamer (CSIVEDGK), NFO4 (VYMNRKYYKCCK), and a 13-mer (GPAGIDGPAGIRC), which were previously generated for OTA-specific recognition, were evaluated using an advanced MD simulation approach involving accelerated configurational search and predictive modeling. Peptide configurations relevant to ochratoxin binding were initially generated using biased exchange metadynamics and the dynamic properties associated with the in-solution peptide-ochratoxin binding were derived from Markov State Models. Among the various peptides, NFO4 shows superior in-solution OTA sensing and also shows superior selectivity for OTA vs. OTB due to the lower penalty associated with solvating its bound complex. Advanced MD approaches provide structural and energetic insights critical to the hapten-specific recognition to aid the engineering of peptides with better sensing efficacies.

Indexed as

Binding SitesHaptensMolecular Dynamics SimulationOchratoxinsPeptidesSolventsHaptensochratoxin Aochratoxin BOchratoxinsPeptidesSolventsbiased exchange metadynamicsbinding free energyMarkov state modelmolecular dynamicsmycotoxin recognitionNFO4ochratoxinspeptidesolvation penaltytoxins

Identifiers

PMID28505090
PMCPMC5450712
OpenAlexW2612519366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.